Cargando…
Bispecific Antibodies: A New Era of Treatment for Multiple Myeloma
Despite the introduction of novel agents such as proteasome inhibitors, immunomodulatory drugs, and autologous stem cell transplant, multiple myeloma (MM) largely remains an incurable disease. In recent years, monoclonal antibody-based treatment strategies have been developed to target specific surf...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408718/ https://www.ncbi.nlm.nih.gov/pubmed/32659909 http://dx.doi.org/10.3390/jcm9072166 |